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Abstract 1 
Signaling molecules derived from attachment of diverse metabolic building blocks to 2 
ascarosides play a central role in the life history of C. elegans and other nematodes; however, 3 
many aspects of their biogenesis remain unclear. Using comparative metabolomics, we show 4 
that a pathway mediating formation of intestinal lysosome-related organelles (LROs) is required 5 
for biosynthesis of most modular ascarosides as well as previously undescribed modular 6 
glucosides. Similar to modular ascarosides, the modular glucosides are derived from highly 7 
selective assembly of moieties from nucleoside, amino acid, neurotransmitter, and lipid 8 
metabolism, suggesting that modular glucosides, like the ascarosides, may serve signaling 9 
functions. We further show that carboxylesterases that localize to intestinal organelles are 10 
required for the assembly of both modular ascarosides and glucosides via ester and amide 11 
linkages. Further exploration of LRO function and carboxylesterase homologs in C. elegans and 12 
other animals may reveal additional new compound families and signaling paradigms. (147 13 
Words) 14 
 15 
 16 
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Introduction 1 
Recent studies indicate that the metabolomes of animals, from model systems such as 2 
Caenorhabditis elegans and Drosophila to humans, may include >100,000 of compounds1,2. 3 
The structures and functions of most of these small molecules have not been identified, 4 
representing a largely untapped reservoir of chemical diversity and bioactivities. In C. elegans3 a 5 
large modular library of small-molecule signals, the ascarosides, are involved in almost every 6 
aspect of its life history, including aging, development, and behavior4-7. The ascarosides 7 
represent a structurally diverse chemical language, derived from glycosides of the dideoxysugar 8 
ascarylose and hydroxylated short-chain fatty acid (Fig. 1a)8. Structural and functional specificity 9 
arises from optional attachment of additional moieties to the sugar, for example indole-3-10 
carboxylic acid (e.g. icas#3 (1)), or carboxy-terminal additions to the fatty acid chain, such as p-11 
aminobenzoic acid (PABA, as in ascr#8 (2)) or O-glucosyl uric acid (e.g. uglas#11 (3), Fig. 12 
1b)2,9-13. Given that even small changes in the chemical structures of the ascarosides often 13 
result in starkly altered biological function, ascaroside biosynthesis appears to correspond to a 14 
carefully regulated encoding process in which biological state is translated into chemical 15 
structures14. Thus, the biosynthesis of ascarosides and other C. elegans signaling molecules 16 
(e.g. nacq#1)15 represents a fascinating model system for the endogenous regulation of inter-17 
organismal small-molecule signaling in metazoans. However, for most of the >200 recently 18 
identified C. elegans metabolites2,8,9, biosynthetic knowledge is sparse. Previous studies have 19 
demonstrated that conserved metabolic pathways, e.g. peroxisomal β-oxidation9,10 and amino 20 
acid catabolism8,16 (Fig. 1a), contribute to ascaroside biosynthesis; however, many aspects of 21 
the mechanisms underlying assembly of multi-modular metabolites remains unclear. 22 
Recently, metabolomic analysis of mutants of the Rab-GTPase glo-1, which lack a 23 
specific type of lysosome-related organelles (LROs, also referred to as autofluorescent gut 24 
granules), revealed complete loss of 4′-modified ascarosides14. The glo-1-dependent LROs are 25 
acidic, pigmented compartments that are related to mammalian melanosomes and drosophila 26 
eye pigment organelles17,18. LROs form when lysosomes fuse with other cellular compartments, 27 
e.g. peroxisomes, and appear to play an important role for recycling proteins and metabolites17. 28 
Additionally, it has been suggested that LROs may be involved in the production and secretion 29 
of diverse signaling molecules19,20, and the observation that glo-1 mutant worms are deficient in 30 
4′-modified ascarosides suggested that intestinal organelles may serve as hubs for their 31 
assembly (Fig. 1a)14. In addition to the autofluorescent LROs, several other types of intestinal 32 
granules have been characterized in C. elegans, including lipid droplets21 and lysosome-related 33 
organelles that are not glo-1-dependent 22. 34 
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Parallel studies of other Caenorhabditis species23-25 and Pristionchus pacificus26, a 1 
nematode species being developed as a satellite model system to C. elegans27, revealed that 2 
production of modular ascarosides is widely conserved among nematodes. Leveraging the high 3 
genomic diversity of sequenced P. pacificus isolates, genome-wide association studies coupled 4 
to metabolomic analysis revealed that uar-1, a carboxylesterase from the α/ß-hydrolase 5 
superfamily with homology to cholinesterases (AChEs), is required for 4′-attachment of an 6 
ureidoisobutyryl moiety to a subset of ascarosides, e.g. ubas#3 (4, Fig. 1c)26. Homology 7 
searches revealed a large expansion of carboxylesterase (cest) homologs in P. pacificus as well 8 
as C. elegans (Fig. S1), and recently it was shown that in C. elegans, the uar-1 homologs cest-9 
3, cest-8, and cest-9.2 are involved in the 4′-attachment of other acyl groups in modular 10 
ascarosides28. Based on these findings, we posited that cest homologs localize to glo-1-11 
dependent intestinal granules where they control assembly of modular ascarosides, and 12 
perhaps other modular metabolites. In this work, we present a comprehensive assessment of 13 
the impact of glo-1-deletion on the C. elegans metabolome and uncover the central role of cest 14 
homologs that localize to intestinal granules in the biosynthesis of diverse modular metabolites. 15 
 16 
Results 17 
Novel classes of LRO-dependent metabolites. To gain a comprehensive overview of the role 18 
of glo-1 in C. elegans metabolism, we employed a fully untargeted comparison of the 19 
metabolomes of a glo-1 null mutant and wildtype worms (Fig. 1d). HPLC-high resolution mass 20 
spectrometry (HPLC-HRMS) data for the exo-metabolomes (excreted compounds) and endo-21 
metabolomes (compounds extractable from the worm bodies) of the two strains were analyzed 22 
using the Metaboseek comparative metabolomics platform, which integrates the xcms 23 
package29. These comparative analyses revealed that the glo-1 mutation has a dramatic impact 24 
on C. elegans metabolism. For example, in negative ionization mode we detected >1000 25 
molecular features that were at least 10-fold less abundant in the glo-1 exo- and endo-26 
metabolomes, as well as >3000 molecular features that are 10-fold upregulated in glo-1 27 
mutants. For further characterization of differential features, we employed tandem mass 28 
spectrometry (MS2) based molecular networking, a method which groups metabolites based on 29 
shared fragmentation patterns (Fig. 1d, S2-5)30. The resulting four MS2 networks – for data 30 
obtained in positive and negative ionization mode for the exo- and endo-metabolomes – 31 
revealed several large clusters of features whose abundances were largely abolished or greatly 32 
increased in glo-1 worms. Notably, although some differential MS2 clusters represented known 33 
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compounds, e.g. ascarosides, the majority of clusters were found to represent previously 1 
undescribed metabolite families.   2 
In agreement with previous studies14, biosynthesis of most modular ascarosides was 3 
abolished or substantially reduced in glo-1 mutants, including all 4′-modified ascarosides, e.g. 4 
icas#3 (1) (Figs. 1b, and S6a). Similarly, production of ascarosides modified at the carboxy 5 
terminus, e.g. uglas#11 (3) derived from ester formation between ascr#1 (5) and uric acid 6 
glucoside12 (6), and ascr#8 (2), derived from formation of an amide bond between ascr#7 (7) 7 
and of p-amino benzoic acid (8), was largely abolished in glo-1 mutants (Figs. 1a, 1b, and S6a). 8 
Metabolites plausibly representing building blocks of these modular ascarosides were not 9 
strongly perturbed in glo-1 mutants (Fig. S7). For example, abundances of unmodified 10 
ascarosides, e.g. ascr#3 (9) and ascr#10 (10), or metabolites representing 4′-modifications, e.g. 11 
indole-3-carboxylic acid (11) and octopamine succinate (12), were not significantly perturbed in 12 
the mutant (Figs. 1a, S6a and S7). In contrast, a subset of modular ascaroside glucose esters 13 
(e.g. iglas#1 (13) and glas#10 (14), Fig. 1e), was strongly increased in glo-1 mutants (Fig. S6b). 14 
These results suggest that glo-1-dependent intestinal organelles function as a central hub for 15 
the biosynthesis of most modular ascarosides, with the exception of a subset of ascarosylated 16 
glucosides, whose increased production in glo-1 mutants may be indicative of a shunt pathway 17 
for ascarosyl-CoA derivatives31-33, which represent plausible precursors for modular ascarosides 18 
modified at the carboxy terminus.  19 
Next, we analyzed the most prominent MS2 clusters representing previously 20 
uncharacterized metabolites whose production is abolished or strongly reduced in glo-1 mutants 21 
(Fig. 2). Detailed analysis of their MS2 spectra indicated that they may represent a large family 22 
of modular hexose derivatives incorporating moieties from diverse primary metabolic pathways. 23 
For example, MS2 spectra from clusters I, II, and III of the positive-ionization network suggested 24 
phosphorylated hexose glycosides of indole, anthranilic acid, tyramine, or octopamine, which 25 
are further decorated with a wide variety of fatty acyl moieties derived from fatty acid or amino 26 
acid metabolism, for example nicotinic acid, pyrrolic acid, or tiglic acid (Fig. 2, Table 1)17,34. 27 
Given the previous identification of the glucosides iglu#1/2 (15/16, Fig. 2e) and angl#1/2 28 
(17/18), we hypothesized that clusters I, II, and III represent a modular library of glucosides, in 29 
which N-glucosylated indole, anthranilic acid, tyramine, or octopamine35 serve as scaffolds for 30 
attachment of diverse building blocks. To further support these structural assignments, a series 31 
of modular metabolites based on N-glucosylated indole (“iglu”) were selected for total synthesis. 32 
Synthetic standards for the non-phosphorylated parent compounds of iglu#4 (19), iglu#6 (20), 33 
iglu#8 (21), and iglu#10 (22) matched HPLC retention times and MS2 spectra of the 34 
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corresponding natural compounds (Fig. S8), confirming their structures and enabling tentative 1 
structural assignments for a large number of additional modular glucosides, including their 2 
phosphorylated derivatives, e.g. iglu#12 (23), iglu#41 (24), angl#4 (cluster II, 25), and tyglu#4 3 
(cluster III, 26) (Fig. 2). The proposed structures include several glucosides of the 4 
neurotransmitters tyramine and octopamine, whose incorporation could be verified by 5 
comparison with data from a recently described feeding experiment with stable isotope labeled 6 
tyrosine35. Similar to ascaroside biosynthesis, the production of modular glucosides is life stage 7 
dependent; for example, production of specific tyramine glucosides peaks at the L3 larval stage, 8 
whereas production of angl#4 increases until the adult stage (Figs. S9 and S10). Notably, 9 
modular glucosides were detected primarily as their phosphorylated derivatives, as respective 10 
non-phosphorylated species were generally less abundant. In contrast to most ascarosides, the 11 
phosphorylated glucosides are more abundant in the endo-metabolome than the exo-12 
metabolome, suggesting that phosphorylated glucosides may be specifically retained in the 13 
body (Fig. S9).  14 
As in the case of modular ascarosides, the abundances of putative building blocks of the 15 
newly identified modular glucosides were not strongly perturbed in glo-1 mutants. For example, 16 
abundances of anthranilic acid, indole, octopamine, and tyramine were not significantly affected 17 
in glo-1 null animals (Fig. S11). Notably, abundances of the glucosides scaffold, e.g. iglu#1 and 18 
angl#1, were also largely unaltered or even slightly increased in glo-1 mutants (Fig. S11). In 19 
addition, production of some of the identified modular glucosides, e.g. iglu#5, is reduced but not 20 
fully abolished in glo-1 worms (Fig. S8).  21 
To confirm our results, we additionally compared the glo-1 metabolome with that of glo-4 22 
mutants. glo-4 encodes a predicted guanyl-nucleotide exchange factor acting upstream of glo-1, 23 
and like glo-1 mutants, glo-4 worms do not form LROs18. We found that the glo-4 metabolome 24 
closely resembles that of glo-1 worms, lacking most of the modular ascarosides and 25 
ascarosides detected in wildtype worms (Fig. S6c). Correspondingly, similar sets of compounds 26 
are upregulated in glo-1 and glo-4 mutants relative to wildtype, including ascarosyl glucosides 27 
and ascaroside phosphates. Compounds accumulating in glo-1 and glo-4 mutant worms further 28 
include a diverse array of small peptides (primarily three to six amino acids), consistent with the 29 
proposed role of LROs in the breakdown of peptides derived from proteolysis (Fig. S12)36. 30 
Taken together, our results indicate that, in addition to their roles in the degradation of metabolic 31 
waste, the LROs serve as hotspots of biosynthetic activity, where building blocks from diverse 32 
metabolic pathways are attached to glucoside and ascaroside scaffolds (Fig. 1a).  33 
 34 
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Carboxylesterases are required for modular assembly. Comparing the relative abundances 1 
of different members of the identified families of modular glucosides and ascarosides, it appears 2 
that combinations of different building blocks and scaffolds are highly specific, suggesting the 3 
presence of dedicated biosynthetic pathways. For example, uric acid glucoside, gluric#1 (6), is 4 
preferentially combined with an ascaroside bearing a 7-carbon side chain (to form uglas#11, 3), 5 
whereas ascarosides bearing a 9-carbon side chain are preferentially attached to the anomeric 6 
position of free glucose, as in glas#10 (14)2,8. Similarly, tiglic acid is preferentially attached to 7 
indole and tyramine glucosides but not to anthranilic acid glucosides (Table 1). Given that 4′-8 
modification of ascarosides in P. pacificus and C. elegans require cest homologs, we 9 
hypothesized that the biosynthesis of other modular ascarosides as well as the newly identified 10 
glucosides may be under the control of cest family enzymes26,28. From a list of 44 uar-1 11 
homologs from BLAST analysis (Table 2), we selected seven for further study (Fig. 3a, S2). The 12 
selected homologs are predicted to have intestinal expression, one primary site of small 13 
molecule biosynthesis in C. elegans2, and are closely related to the UAR-1 gene, while 14 
representing different sub-branches of the phylogenetic tree. Utilizing a recently optimized 15 
CRISPR/Cas9 method, we obtained two null mutant strains for five of the selected genes37. 16 
Mutants for the remaining two homologs, ges-1 and cest-6, had been previously obtained (Table 17 
3). We then analyzed the exo- and endo-metabolomes of this set of mutant strains by HPLC-18 
HRMS to identify features that are absent or strongly downregulated in null mutants of a specific 19 
candidate gene compared to wildtype worms and all other mutants in this study. We found that 20 
two of the seven tested homologs (cest-1.1, cest-2.2) are defective in the production of two 21 
different families of modular ascarosides, whereas cest-4 mutants were defective in the 22 
biosynthesis of a specific subset of modular indole glucosides (Fig. 3). The metabolomes of 23 
mutants for the remaining four cest homologs did not exhibit any significant differences 24 
compared to wildtype under the tested conditions.   25 
Analysis of the metabolomes of the two cest-2.2 null mutants revealed loss of dauer 26 
pheromone component and male attractant ascr#8 (2) as well as of the closely related ascr#81 27 
(27) and ascr#82 (28) (Fig. 3b, S13a). Biosynthetically, the ascr#8 family of ascarosides are 28 
derived from amide formation between ascr#7 (ΔC7, 7) and folate-derived p-aminobenzoic acid 29 
(PABA, 8), PABA-glutamate (29), or PABA-diglutamate, respectively. We did not detect any 30 
significant reduction in the production of plausible ascr#8 precursors, including PABA and 31 
PABA-glutamate, or ascr#7 (Fig. 3c, S14b). Biosynthesis of ascr#8, ascr#81, and ascr#82 was 32 
recovered in cest-2.2 mutant worms in which the cest-2.2 sequence had been restored to wild 33 
type using CRISPR/Cas9 (Fig. 3c, S15b). These results indicate that CEST-2.2 is required 34 
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specifically for biosynthesis of the amide linkage between the carboxy terminus of ascr#7 and 1 
PABA derivatives, in contrast to the implied functions of UAR-1, CEST-8, CEST-3, and CEST-2 
9.2, which are involved in the formation of ester bonds between various head groups and the 4′-3 
hydroxy group of ascarylose26,28.  4 
In cest-1.1 null mutants (cest-1.1(null)), biosynthesis of the nucleoside-like ascaroside 5 
uglas#1 (30) and its phosphorylated derivative uglas#11 (3) was abolished (Fig. 3d, S13c). 6 
uglas#1 and uglas#11 are derived from the attachment of ascr#1, bearing a seven carbon (C7) 7 
side chain, to the uric acid gluconucleoside gluric#1 (6). Production of ascr#1 (5) and gluric#1 8 
(6), representing plausible building blocks of uglas#1 (30), was not reduced (Fig. S14a). 9 
Furthermore, production of uglas#14 (31) and uglas#15 (32), isomers of uglas#1 and uglas#11 10 
bearing the ascarosyl moiety at the 6′ position instead of the 2′ position, was not abolished but 11 
rather slightly increased in cest-1.1(null) (Fig. 3d-e). These results indicate that CEST-1.1 is 12 
required for the formation of the ester bond specifically between ascr#1 (5) and the 2′-hydroxyl 13 
group in gluric#1. As in the case of cest-2.2, biosynthesis of uglas#1 and uglas#11 was fully 14 
recovered in cest-1.1 mutant worms in which the cest-1.1 sequence had been restored to wild 15 
type using CRISPR/Cas9 (Fig. 3f, S15a).  16 
Sequence alignment with human AChE suggested that serine 213 is part of the 17 
conserved catalytic serine-histidine-glutamate triad of CEST-1.1 (Fig. S16). To test whether 18 
disruption of the catalytic triad would affect production of cest-1.1-dependent metabolites, we 19 
generated a point mutant, cest-1.1(S213A). As in cest-1.1(null), production of uglas#1 (30) and 20 
uglas#11 (3) was fully abolished in cest-1.1(S213A), whereas production of gluric#1 was not 21 
affected (Fig. 3g).  22 
Previous work implicated cest-1.1 with longevity phenotypes associated with argonaute-23 
like gene 2 (alg-2)38. alg-2 mutant worms are long lived compared to wild type and their long 24 
lifespan was further shown to require daf-16, the sole ortholog of the FOXO family of 25 
transcription factors in C. elegans, as well as cest-1.1. Moreover, uglas#11 biosynthesis is 26 
significantly increased in mutants of the insulin receptor homolog daf-2, a central regulator of 27 
lifespan in C. elegans upstream of daf-1612. These findings suggest the possibility that the 28 
production of uglas ascarosides underlies the cest-1.1-dependent extension of adult lifespan in 29 
C. elegans.  30 
 In contrast to our results for cest-1.1 and cest-2.2 mutants, comparative metabolomic 31 
analysis of the cest-4 mutant strains did not reveal any defects in the biosynthesis of known 32 
ascarosides. Instead, we found that the levels of a specific subset of modular anthranilic acid 33 
(33) bearing indole glucosides, including iglu#3 (34) and its phosphorylated derivative iglu#4 34 
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(35) were abolished in the cest-4 mutant worms (Fig. 3h, S13b). Abundances of the putative 1 
precursor glucosides, iglu#1 (15) and iglu#2 (16), were not significantly changed in cest-4 (Fig. 2 
3i, S14c). Notably, production of other indole glucosides, e.g. iglu#6 (36) and iglu#8 (37), was 3 
not significantly reduced in cest-4 worms (Fig. 3i, S17). Biosynthesis of iglu#3 and iglu#4 was 4 
restored to wild type levels in genetic revertant strains for cest-4 (Fig. 3i, S15c). Therefore, it 5 
appears that cest-4 is specifically required for attachment of anthranilic acid to the 6′ position of 6 
glucosyl indole precursors, whereas attachment of tiglic acid, nicotinic acid, and other moieties 7 
is cest-4-independent (Fig. 3j, S17). The role of cest-4 in the biosynthesis of the iglu family of 8 
modular glucosides thus parallels that of cest-1.1 in the biosynthesis of the uglas ascarosides: 9 
whereas cest-4 appears to be required for the attachment of anthranilic acid (33) to the 6’ 10 
position of a range of indole glucosides, cest-1.1 appears to be required for attaching the ascr#1 11 
side chain to the 2′ position in uric acid glucosides. 12 
 13 
CEST-2.2 localizes to intestinal granules. All cest homologs selected for this study exhibit 14 
domain architectures typical of the α/ß-hydrolase superfamily of proteins, including a conserved 15 
catalytic triad, and further contain a predicted disulfide bridge, as in mammalian AChE39 (Fig. 16 
S16). The cest genes also share homology with neuroligin, a membrane bound member of the 17 
α/ß-hydrolase fold family, that mediates the formation and maintenance of synapses between 18 
neurons40. Sequence analysis suggests that five of the seven CEST homologs studied here are 19 
membrane anchored (Fig. S18), given the presence of a predicted C-terminal transmembrane 20 
domain41 (consisting of ~20 residues), with the N terminus on the luminal side of a vesicle or 21 
organelle (Fig. S18). Since the production of all so far identified cest-dependent metabolites is 22 
abolished in glo-1 mutants, it seemed likely that the CEST proteins localize to intestinal 23 
granules. To test this idea, we created a mutant strain that express cest-2.2 C-terminally tagged 24 
with mCherry at the native genomic locus to avoid potentially confounding effects of 25 
overexpression. The red fluorescent mCherry was chosen because of the strong green 26 
autofluorescence of the LROs17. We confirmed that production of all cest-2.2-dependent 27 
metabolites, including ascr#8 (2), ascr#81 (27), and ascr#82 (28) was not significantly altered in 28 
cest-2.2-mCherry mutants (Fig. 4a), indicating that CEST-2.2 remained functional. Imaging of 29 
wildtype adult worms revealed strong green and weaker red autofluorescence in circular 30 
features in intestinal cells, consistent with LROs. In addition, cest-2.2-mCherry-tagged worms 31 
showed red fluorescence in a distinct set of intestinal granules that showed little if any 32 
autofluorescence (Fig. 4b, S19, S20). It is unclear whether mCherry also localizes to the 33 
strongly autofluorescent granules, as we cannot distinguish the mCherry signal from the red 34 
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component of the autofluorescence, given relatively low CEST-2.2-mCherry expression in this 1 
non-overexpressing strain. Taken together, it appears that CEST-2.2-mCherry localizes to a 2 
subset of intestinal organelles that is partly distinct from the autofluorescent LROs. Further 3 
studies are required to determine if CEST-2.2-mCherry co-localizes with other intestinal granule 4 
markers, specifically GLO-1 and the lysosomal marker LMP-1. 5 
 6 
Glo-1-dependent metabolites in C. briggsae. In addition to C. elegans and P. pacificus, 7 
modular ascarosides have been reported from several other Caenorhabditis species42,43, 8 
including C. briggsae23,44. To assess whether the role of LROs in the biosynthesis of modular 9 
metabolites is conserved across species, we created two Cbr-glo-1 (CBG01912.1) knock-out 10 
strains using CRISPR/Cas9. As in C. elegans, Cbr-glo-1 mutant worms lacked autofluorescent 11 
LROs, which are prominently visible in wildtype C. briggsae (Fig. S21). Comparative 12 
metabolomic analysis of the endo- and exo-metabolomes of wildtype C. briggsae and the Cbr-13 
glo-1 mutant strains revealed that biosynthesis of all known modular ascarosides is abolished in 14 
Cbr-glo-1 worms, including the indole carboxy derivatives icas#2 (35) and icas#6.2 (36), which 15 
are highly abundant in wildtype C. briggsae (Fig. 5a).23 In addition, the C. briggsae MS2 16 
networks included several large Cbr-glo-1-dependent clusters representing modular glucosides, 17 
including many of the compounds also detected in C. elegans, e.g. iglu#4 and angl#4. As in C. 18 
elegans, production of unmodified glucoside scaffolds, e.g. iglu#1 (15) and angl#1 (17), was not 19 
reduced or increased in Cbr-glo-1 mutants, whereas biosynthesis of most modular glucosides 20 
derived from attachment of additional moieties to these scaffolds was abolished (Fig. 5b). Taken 21 
together, these results indicate that the role of LROs as a central hub for the assembly of 22 
diverse small molecule architectures, including modular glucosides and ascarosides, may be 23 
widely conserved among nematodes (Fig. 5c).  24 
 25 
Discussion 26 
Our results indicate that in C. elegans the Rab-GTPase glo-1, which is required for formation of 27 
intestinal LROs, plays a central role in the biosynthesis of several large compound families 28 
derived from modular assembly via cest homologs. Formation of the autofluorescent LROs via 29 
glo-1 is reminiscent of the roles of its human orthologs RAB32 and RAB38, which are required 30 
for the formation of melanosomes, and perhaps other LROs45,46. Lysosomes and LROs are 31 
generally presumed to function in autophagy, phagocytosis, and the hydrolytic degradation of 32 
proteins, and Rab32 family GTPases have been shown to be required for these processes in 33 
diverse organisms47. Consistent with the notion that lysosomes and LROs are degradation 34 
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hotspots, many of the building blocks of the identified modular ascarosides and glucosides are 1 
derived from catabolic pathways, for example, anthranilic acid is derived from tryptophan 2 
catabolism, uric acid stems from purine metabolism, and the short chain ascarosides are the 3 
end products of peroxisomal β-oxidation of very long-chain precursors. Importantly, although our 4 
results indicate that carboxylesterases participate in glo-1-dependent modular metabolite 5 
assembly, additional studies are required to clarify whether the intestinal compartments that 6 
carboxylesterases localize to also contain GLO-1 and the lysosomal marker LMP-1, as is the 7 
case for the autofluorescent LROs22. 8 
Further, our results demonstrate that the modular assembly paradigm extends beyond 9 
ascarosides. The modular glucosides represent a previously unknown family of nematode 10 
metabolites. In contrast to the well-established role of modular ascarosides as pheromones, it is 11 
unknown whether modular glycosides serve specific biological functions, e.g., as signaling 12 
molecules; however, their specific biosynthesis via cest-4 as well as their life stage-dependent 13 
production strongly supports this hypothesis (Fig. S10). Like the ascaroside pheromones, some 14 
modular glucosides are excreted into the media, suggesting that they could be involved in inter-15 
organismal communication. Identifying developmental and environmental conditions that affect 16 
modular glucoside production, as well as a more comprehensive understanding of their 17 
biosyntheses, may help uncover potential signaling and other biological roles. In particular, the 18 
apparent peroxisomal origin of the ascaroside scaffolds suggests a link between peroxisome 19 
and gut granule activity, perhaps via pexophagy48, and characterization of the role of autophagy 20 
for gut granule-dependent metabolism may contribute to uncovering the functions of modular 21 
glucoside and ascarosides. A connection to autophagy is also suggested by our previous 22 
finding14 that production of modular ascarosides is reduced in mutants of atg-1849, which is 23 
essential for autophagy.   24 
The high degree of selectivity in which different building blocks are combined in the 25 
modular ascarosides and glucosides strongly suggests that these compounds, despite their 26 
numbers and diversity, represent products of dedicated enzymatic pathways, as has recently 27 
been established for 4′-acylated ascarosides. Our results revealed a wider range of biosynthetic 28 
functions associated with cest homologs, including esterification and amide formation at the 29 
carboxy terminus of ascarosides and acylation of glucosides (Figure 5c). Notably, all cest null 30 
mutants whose metabolomes have been characterized so far are defective in the biosynthesis 31 
of one or a few compounds sharing a specific structural feature, further supporting the view that 32 
these selectively assembled molecular architectures serve dedicated functions.  33 
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All CEST proteins that so far have been associated with modular metabolite assembly 1 
contain membrane-anchors and exhibit domain architectures typical of serine hydrolases of the 2 
AChE family, including an α/β-hydrolase fold, a conserved catalytic serine-histidine-glutamate 3 
triad, and bridging disulfide cysteines (Fig. S16)39. While our efforts at heterologous expression 4 
of CEST proteins were unsuccessful, the finding that mutation of the catalytic serine in cest-5 
1.1(S213A) abolished production of all cest-1.1-dependent compounds suggests that CEST 6 
enzymes directly participate in the biosynthesis of modular metabolites. Therefore, we 7 
hypothesize that CEST proteins, after translating from the endomembrane system to glo-1-8 
dependent intestinal organelles, partake in the assembly of diverse ascaroside or glucoside-9 
based architectures via acyl transfer from corresponding activated intermediates, e.g. CoA or 10 
phosphate esters39,50. α/β-hydrolase fold enzymes are functionally highly diverse51 and include 11 
esterases, peptidases, oxidoreductases, and lyases, serving diverse biosynthetic roles in 12 
animals, plants52, and bacteria53. While acyltransferase activity is often observed as a side 13 
reaction for esterases and lipases, α/β-hydrolase fold enzymes can function as dedicated 14 
acyltransferases, e.g. in microbial natural product biosyntheses51,54. Additional biochemical 15 
studies will be required to delineate the exact mechanisms by which cest homologs contribute to 16 
modular metabolite assembly in nematodes.  17 
Finally, although our results indicate that glo-1 is required for the biosynthesis of most 18 
modular metabolites we have detected so far, it is notable that some modular ascarosides, e.g. 19 
iglas#1 (13), and modular glucosides, e.g. iglu#6 (20) and iglu#8 (21), do not appear to be glo-20 
1-dependent (Fig. S8). This suggests that diverse cell compartments contribute to modular 21 
metabolite biosynthesis and may also indicate that not all CEST proteins are delivered to the 22 
same cellular compartment. Similarly, glo-1 mutants continue to generate the simple glucosides 23 
and ascarosides that serve as scaffolds for further elaboration via CEST proteins, which may be 24 
derived from UDP-glycosyltransferases55.   25 
Reminiscent of the role of AChE for neuronal signal transduction in animals, it appears 26 
that, in C. elegans, carboxylesterases with homology to AChE have been co-opted to establish 27 
additional signal transduction pathways that are based on a modular chemical language, for 28 
inter-organismal communication, and perhaps also intra-organismal signaling. The biosynthetic 29 
functions of most of the 200 serine hydrolases in C. elegans, including more than 30 additional 30 
cest homologs, remain to be assessed, and it seems likely that this enzyme family contributes to 31 
the biosynthesis of a large number of additional, yet unidentified compounds. Similarly, the 32 
exact enzymatic roles of many families of mammalian serine hydrolases have not been 33 
investigated using HRMS-based untargeted metabolomics. Our results may motivate a 34 
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systematic characterization of metazoan cest homologs and other serine hydrolases, with 1 
regard to their roles in metabolism and small molecule signaling, associated enzymatic 2 
mechanisms, and cellular localization. 3 
 4 
 5 
 6 
 7 
 8 
 9 
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Figures  
 
Figure 1: (a) Modular ascarosides are assembled from simple ascarosides, e.g. ascr#1 (5) or 
ascr#3 (9), and building blocks from other metabolic pathways, e.g. glucosyl uric acid (6), p-
aminobenzoic acid (PABA, 8) indole-3-carboxylic acid (11), or succinyl octopamine (12). We 
hypothesize that glo-1-dependent gut granules play a central role in their biosynthesis. (b) 
Examples for modular ascarosides and their biological context. (c) UAR-1 in P. pacificus 
converts simple ascarosides into the 4′-ureidoisobutyric acid-bearing ascarosides, e.g. ubas#3 
(4). (d) Strategy for comparative metabolomic analysis of LRO-deficient glo-1 mutants. (e) 
Example for modular ascarosides whose production is increased in glo-1 mutants.   
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Figure 2: (a) Partial MS2 network (positive ion mode) for C. elegans endo-metabolome 
highlighting three clusters of modular glucosides that are down regulated in the glo-1 mutants 
(also see Fig. S1-4). Red represents downregulated and blue upregulated features compared to 
wildtype C. elegans. (b) Cluster I feature several modular indole glucoside derivatives. 
Structures were proposed based on MS2 fragmentation patterns, also see Table 1. Compounds 
whose non-phosphorylated analogs were synthesized are marked (*). Shown ion 
chromatograms demonstrate loss of iglu#4 in glo-1 mutants. (c,d) Examples for modular 
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glucosides detected as part of clusters II and III. Ion chromatograms show abolishment of 
angl#4 (25) (c) and tyglu#4 (26) (d) production in glo-1 mutants. (e) Modular glucosides are 
derived from combinatorial assembly of a wide range of building blocks. Incorporation of 
moieties was confirmed via total synthesis of example compounds (green) or stable isotope 
labeling (blue). For all compounds, 3-phosphorylation was proposed based on the established 
structures of iglu#2 (16), angl#2 (18), and uglas#11 (3). 
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Figure 3: (a) Phylogenetic tree relating P. pacificus uar-1 to homologous predicted genes in C. 
elegans. Ppa-uar-1, cest-3, cest-8, cest-9.2 (green) mediate ester formation at the 4′-position of 
ascarosides in P. pacificus and C. elegans. Genes shown in red color were selected for the 
current study. (b,c) Production of ascr#8 (2), ascr#81 (27), and ascr#82 (28) is abolished in 
cest-2.2 mutants Isogenic revertant strains of the cest-2.2 null mutants in which the STOP-IN 
cassette was precisely excised, demonstrate wildtype-like recovery of the associated 
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metabolite. (d,e) Production of uglas#1 and uglas#11 is abolished in cest-1.1(null) mutants and 
recovered in genetic revertants. (f) Biosynthesis of positional isomers uglas#14 (31) and 
uglas#15 (32) is unaltered or increased in cest-1.1 mutants (f). (g) Production of uglas#1 and 
uglas#11, but not gluric#1, is abolished in cest-1.1(S213) mutants. (h,i) Production of the 
anthranilic acid-modified glucoside iglu#4 is largely abolished in cest-4 mutants and fully 
recovered in genetic revertants. (j) Production of iglu#6 (36) and iglu#8 (37), whose structures 
are closely related to that of iglu#4, is not abolished in cest-4 mutants. Ion chromatograms in 
panels b, d, and g further demonstrate abolishment in glo-1 mutants. n.d., not detected. Error 
bars are standard deviation of the mean, and p-values are depicted in the Figure.  
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Figure 4: (a) Relative amounts of cest-2.2 dependent metabolites in worms expressing C-
terminally mCherry-tagged CEST-2.2. (b) Red fluorescence in intestinal granules in wildtype 
and cest-2.2-mCherry gravid adults. Top, wildtype (N2) control; bottom, cest-2.2-mCherry 
worms. 
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Figure 5: Relative abundance of (a) simple and modular ascarosides and (b) simple and 
modular glucosides in the endo-metabolome of Cbr-glo-1 mutants relative to wildtype C. 
briggsae. n.d., not detected. (c) Model for modular metabolite assembly. CEST proteins 
(membrane-bound in the LROs, red) mediate attachment of building blocks from diverse 
metabolic pathways to glucose scaffolds and peroxisomal β-oxidation-derived ascarosides via 
ester and amide bonds. Some of the resulting modular ascarosides may undergo additional 
peroxisomal β-oxidation following activation by acs-725.  
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Methods 
General information. Unless noted otherwise, all reagents were purchased from Sigma-
Aldrich. All newly identified compounds were assigned four letter “SMID”s (a search-compatible, 
Small Molecule IDentifier) e.g., “icas#3” or “ascr#10”. The SMID database (www.smid-db.org) is 
an electronic resource maintained in collaboration with WormBase (www.wormbase.org). A 
complete list of SMIDs can be found at www.smid-db.org/browse, and example structures for 
different SMIDs at www.smid-db.org/smidclasses. 
BLAST analysis of uar-1. Amino acid sequence of Ppa-UAR-1 was used as previously 
published26. BLASTp was run from the WormBase engine at 
(https://wormbase.org/tools/blast_blat). E-value threshold was set to 1E0. Database was set to 
WS269 and species was set to C. elegans. Results of BLASTp search are listed in Table 2. 
Amino acid sequence alignment. hAChE was aligned with Ppa-UAR-1, CEST-1.1, CEST-2.2, 
and CEST-4 was done using T-Coffee Multiple Sequence alignment56. Protein sequences for C. 
elegans CEST proteins are from WormBase. The AChE sequence was obtained from NCBI 
(accession number P22303). Amino acids were colored based on chemical properties: 
AVFPMILW = red (small + hydrophobic), DE = blue (acidic), RHK = magenta (basic), 
STYHCNGQ = green (hydroxyl + sulfhydryl + amine + glycine). See Figure S17 for results. 
Phylogenetic tree. The protein sequence of Ppa-UAR1 was submitted to an NCBI BLASTp 
search57 (restricted to species C. elegans, conditional compositional BLOSUM62, gap open 
cost:11, gap extension cost: 1, word size: 6) using Geneious software (Biomatters Inc). The top 
BLAST hits by E-value up to and including ace-3 were selected, and only the best scoring 
transcript variant was kept for each protein sequence hit. A total of 28 sequences were then 
imported into MEGA758 and aligned using MUSCLE59 (settings: gap open penalty: -2.9, gap 
extend 0, hydrophobicity multiplier 1.2, max. iterations 8, clustering method for all iterations: 
UPGMB, minimal diagonal length: 24). From this alignment, an Maximum Likelihood tree was 
built based on the JTT matrix-based model60. Initial trees were built by applying Neighbor-Join 
and BioNJ algorithms to a matrix of pairwise distances estimated using a JTT model assuming 
uniform substitution rates across positions. Phylogeny confidence was tested using 200 
bootstrap replications. The tree with the highest log likelihood (-22299.9282) is shown. At each 
branch, the percentage of bootstrap replicates containing the same branching event is denoted. 
The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. 
The evolutionary history was inferred by using the Maximum Likelihood method based on the 
JTT matrix-based model60. The tree with the highest log likelihood (-22299.9282) is shown. The 
percentage of trees in which the associated taxa clustered together is shown next to the 
branches. Initial tree(s) for the heuristic search were obtained automatically by applying 
Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using a JTT 
model, and then selecting the topology with superior log likelihood value. The tree is drawn to 
scale, with branch lengths measured in the number of substitutions per site. The analysis 
involved 28 amino acid sequences. All positions containing gaps and missing data were 
eliminated. There were a total of 427 positions in the final dataset. Evolutionary analyses were 
conducted in MEGA758,61. 
Nematode strains. Wildtype (N2) and glo-1(zu437) null animals were provided by the 
Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research 
Infrastructure Programs (P40 OD010440). cest-2.2 mutant strain integrating N-terminal 
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(mCherry-cest-2.2) or C-terminal mCherry (cest-2.2-mCherry), were generated by SunyBiotech. 
Generation of C. elegans and C. briggsae null mutants and revertants as well as generation of 
the cest-1.1 point mutant is described below. See Table 3 for a complete list of strains used in 
this study. 
C. elegans CRISPR mutagenesis for generation of cest null mutants. CRISPR/Cas9 
mutagenesis was performed as in Wang et al., 201837. Briefly, C. elegans strain N2 were gene-
edited by insertion of a 43-base-pair insertion that disrupts translation. Independent 
homozygous mutants were picked among the progeny of heterozygous F1 progeny of injected 
hermaphrodites and given distinct unique allele names. Reversion of mutants was 
accomplished in the same way. 
C. briggsae CRISPR mutagenesis for generation of glo-1 null mutants. The C. briggsae 
glo-1 mutants sy1382 and sy1383 were both created using the briggsae adaptation of the 
STOP-IN cassette method as described in Cohen and Sternberg 201962 and Wang et al. 201837. 
Both strains were made using a successful insertion of the STOP-IN cassette into the middle of 
the first exon using the guide AACAAATCTCCGGATGATTG. To detect the insertion, we used 
forward primer GGGTGACCGCCCATTTATTG and reverse primer 
AAAGGCGCACATCTTGCTTC. 
C. elegans CRISPR mutagenesis for generation of the cest-1.1(dp683) allele encoding the 
S213A catalytic mutant. cest-1(dp683) was generated as previously described63. Briefly, daf-
2(e1368) mutant animals were injected with in-vitro-assembled Cas9-crRNA-tracrRNA 
complexes targeting cest-1.1 and the dpy-10 co-CRISPR gene and two 100bp repair 
oligonucleotides containing the desired cest-1.1 mutation and the dpy-10(cn64) co-CRISPR 
mutation64. Sequences of the cest-1.1 crRNA and repair oligonucleotide are 5’ 
acctacCGCTACTATCATAC 3’ and 5’ GAAATTGAAAACTTTGGAGGAAATAAAAACAG-
AATTACATTGGCAGGGCATGCCGCTGGAGCAAGTATGATAGTAGCGgtaggtcacataaatgataca
tttttg 3’, respectively. F1 Rol progeny of injected animals were picked and screened for the 
presence of the cest-1.1(dp683) mutation after egglay. F2 broods of F1 Rol animals that were 
heterozygous for cest-1.1(dp683) were screened for animals that were homozygous for cest-
1.1(dp683) and either wild-type or heterozygous for cn64 at the dpy-10 locus. Subsequent 
broods were screened for wild-type dpy-10 animals to remove the co-CRISPR mutation. 
Nematode imaging. To image, gravid adult C. elegans were transferred to an agarose pad on 
a glass slide with 10 µM of levamisole to immobilize the worms. Microscopic analysis was 
performed using a Leica TCS SP5 Laser Scanning Confocal Microscope. Green 
autofluorescence was excited at 488 nm and the emission detector was set to 490-540 nm. 
mCherry was excited with 561 nm and the emission detector was set to 590-650 nm. Worms 
were imaged using the 100x objective. 
C. briggsae imaging. 0.5 mL of 2 µM Lysotracker Deep Red (Thermo Fisher 1 mM stock in 
DMSO) was added to a 6 cm NGM plate seeded with 0.1 mL of E. coli OP50 and incubated in 
the dark for 24 hours at 20 °C. L4 larvae of C. briggsae were added to the plate and allowed to 
grow in the dark for 24 hours at 20 °C. To image, C. briggsae were transferred to an agarose 
pad on a glass slide with 10 µM of levamisole to immobilize the worms. Microscopic analysis 
was performed using a Zeiss Axio Imager Z2 florescence microscope with Apotome.  
Nematode cultures, mixed stage. Culturing began by chunking C. elegans or C. briggsae onto 
10 cm NGM plates (each seeded with 800 µL of OP50 E. coli grown to stationary phase in 
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Lennox Broth) and incubated at 22 °C. Once the food was consumed, the cultures were 
incubated for an additional 24 hours. Each plate was then washed with 25 mL of S-complete 
medium into a 125 mL Erlenmeyer flask, and 1 mL of OP50 E. coli was added (E. coli cultures 
were grown to stationary phase in Terrific Broth, pelleted and resuspended at 1 g wet mass per 
1 mL M9 buffer), shaking at 220 RPM and 22 °C. After 70 hours, cultures were centrifuged at 
5000 G for 1 min. After discarding supernatant, 24 mL H2O was added, along with 6 mL bleach, 
900 µL 10 M NaOH and the mixture was shaken for 3 min to prepare eggs. Eggs were 
centrifuged at 5000 G, the supernatant was removed, and the egg pellet washed with 35 mL M9 
buffer twice and then suspended in a final volume of 5 mL M9 buffer in a 50 mL centrifuge tube. 
Eggs were counted and placed on a rocker and allowed to hatch as L1 larvae for 24 hours at 22 
°C. 70,000 L1 larvae were seeded in 25 mL cultures of S-complete with 1 mL of OP50 and 
incubated at 220 RPM and 22 °C in a 125 mL Erlenmeyer flask. After 72 hours, cultures were 
fed an additional 1 mL of OP50 and incubation continued. After an additional 48 hours, worms 
were spun at 1000 G 5 min and spent medium was separated from worm body pellet. 
Separated medium and worm pellet were flash frozen over liquid nitrogen until further 
processing. At least three biological replicates were grown for all mutant strains. Mutants were 
grown with parallel wildtype controls, and biological replicates were started on different days.   
Metabolite extraction. Lyophilized pellet and media samples were crushed and homogenized 
by shaking with 2.5 mm steel balls at 1300 rpm for 3 min in 30 s pulses while chilled with liquid 
nitrogen (SPEX sample prep miniG 1600). Thus powdered media and pellet samples were 
extracted with 15 mL methanol in 50 mL centrifuge tubes, rocking overnight at 22 °C. 
Extractions were pelleted at 5000 g for 10 min at 4 °C, and supernatants were transferred to 20 
mL glass scintillation vials. Samples were then dried in a SpeedVac (Thermo Fisher Scientific) 
vacuum concentrator. Dried materials were resuspended in 1 mL methanol and vortexed for 1 
min. Samples were pelleted at 5000 g for 5 min and 22 °C, and supernatants were transferred 
to 2 mL HPLC vials and dried in a SpeedVac vacuum concentrator. Samples were then 
resuspended in 200 μL of methanol, transferred into 1.7 mL Eppendorf tubes, and centrifuged at 
18,000 G for 20 min at 4 °C. Clarified extracts were transferred to fresh HPLC vials and stored 
at -20 °C until analysis.  
Preparation of exo-metabolome samples from staged starved and fed cultures. 40,000 
synchronized L1 larvae were added to 125 mL Erlenmeyer flasks containing 30 mL of S-
complete medium. Worms were fed with 4 mL of concentrated OP-50 and incubated at 20 °C 
with shaking at 160 RPM for: 12 h (L1), 24 h (L2), 32 h (L3), 40 h (L4) and 58 h (gravid adults). 
For preparation of starved samples, each of the stages was starved for 24 h after reaching their 
desired developmental stage in S-complete without OP-50. After incubation for the desired time, 
liquid cultures were centrifuged (1000 x g, 22 °C, 1 min) and supernatants were collected. 
Supernatant was separated from intact OP-50 cells by centrifuging (3000 x g, 22 °C, 5 min) and 
the resulting supernatants (exo-metabolome) were lyophilized. Lyophilized samples were 
homogenized with a dounce homogenizer in 10 mL methanol and extracted on a stirring plate 
(22 °C, 12 h). The resulting suspension was centrifuged (4000 g, 22 °C, 5 min) to remove any 
precipitate before carefully transferring to an LC-MS sample vial. Three biological replicates 
were started on different days.  
Mass spectrometric analysis. High resolution LC-MS analysis was performed on a Thermo 
Fisher Scientific Vanquish Horizon UHPLC System coupled with a Thermo Q Exactive HF 
hybrid quadrupole-orbitrap high-resolution mass spectrometer quipped with a HESI ion source. 
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1 μL of extract was injected and separated using at water-acetonitrile gradient on a Thermo 
Scientific Hypersil GOLD C18 column (150 mm x 2.1 mm 1.9 um particle size 175 Å pore size, 
Thermo Scientific) and maintained at 40 °C. Solvents were all purchased from Fisher Scientific 
as HPLC grade. Solvent A: 0.1% formic acid in water; solvent B: 0.1% formic acid in acetonitrile. 
A/B gradient started at 1% B for 5 min, then from 1% to 100% B over 20 min, 100% for 5 min, 
then down to 1% B for 3 min. Mass spectrometer parameters: 3.5 kV spray voltage, 380 °C 
capillary temperature, 300 °C probe heater temperature, 60 sheath flow rate, 20 auxiliary flow 
rate, 1 spare gas ; S-lens RF level 50.0, resolution 240,000, m/z range 100-1200 m/z, AGC 
target 3e6. Instrument was calibrated with positive and negative ion calibration solutions 
(Thermo-Fisher) Pierce LTQ Velos ESI pos/neg calibration solutions. 
Feature detection and characterization. LC−MS RAW files from each sample were converted 
to mzXML (centroid mode) using MSConvert (ProteoWizard), followed by analysis using the 
XCMS65 analysis feature in METABOseek (metaboseek.com). Peak detection was carried out 
with the centWave algorithm29, values set as: 4 ppm, 320 peakwidth, 3 snthresh, 3100 prefilter, 
FALSE fitgauss, 1 integrate, TRUE firstBaselineCheck, 0 noise, wMean mzCenterFun, -0.005 
mzdiff. XCMS feature grouping values were set as: 0.2 minfrac, 2 bw, 0.002 mzwid, 500 max, 1 
minsamp, FALSE usegroup. METABOseek peak filling values set as: 5 ppm_m, 5 rtw, TRUE 
rtrange. Resulting tables were then processed with the METABOseek Data Explorer. Molecular 
features were filtered for each particular null mutant against all other mutants. Filter values were 
set as: 10 to max minFoldOverCtrl, 15000 to max meanInt, 120 to 1500 rt, 0.95 to max Peak 
Quality as calculated by METABOseek. Features were then manually curated by removing 
isotopic and adducted redundancies. Remaining masses were put on the inclusion list for 
MS/MS (ddMS2) characterization. Positive and negative mode data were processed separately. 
In both cases we checked if a feature had a corresponding peak in the opposite ionization 
mode, since fragmentation spectra in different modes often provide complementary structural 
information. To acquire MS2 spectra, we ran a top-10 data dependent MS2 method on a 
Thermo QExactive-HF mass spectrometer with MS1 resolution 60000, AGC target 1 × 10^6, 
maximum IT (injection time) 50 ms, MS2 resolution 45 000, AGC target 5 × 10^5, maximum IT 
80 ms, isolation window 1.0 m/z, stepped NCE (normalized collision energy) 25, 50, dynamic 
exclusion 3 s. 
Statistical analysis. Peak integration data from HPLC-MS analysis were log-transformed66 
prior to statistical analysis. Significance of differences between average peak areas were then 
assessed using unpaired t-tests. 
MS2-based molecular networking. From the list of differential features, described above, MS2 
data was acquired for these features. To generate the MS2 molecular network, Metaboseek 
version 0.9.6 was used. Using the MS2scans features, differential features were matched with 
their respective MS2 scan, using m/z window of 5 ppm, and a retention time window of 15 sec.  
To construct the molecular network, tolerance of the fragment peaks was set to m/z of 0.002 or 
5 ppm, minimum number of peaks was set to 5, with a 2% noise level. Once the network was 
constructed, cos value of 0.8 was used, and the number of possible connections was simplified 
to 5. 
Serine hydrolase dendrogram. The serine hydrolase list was reported previously67. From this 
list, sequences were inputted into Geneious Prime (version 2020.1.2 Biomatters).  Sequences 
were aligned using Clustal Omega, neighbor joining alignment. Dendrogram tree was generated 
using the Geneious Tree Builder; Genetic distance model Jukes-Cantor, Tree build method 
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UPGMA, no outgroup, Bootstrap resampling, random seed 508,949, 300 interactions, support 
threshold of 1. CEST enzymes were colored red, PPA-UAR-1 was colored blue, and example 
proteases were colored green (Fig. S1).  
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2. Synthetic Procedures 
Synthesis of iglu#1 (15). iglu#1 was synthesized as described previously68. 
Synthesis of angl#1 (17). angl#1 was synthesized as described previously69. 
Synthesis of 2-((tert-butoxycarbonyl)amino)benzoic acid (Boc-AA, SI-1). 
 
 
To a solution of anthranilic acid (33, 300 mg, 2.18 mmol) in 4 mL of THF and H2O (1:1), Boc-
anhydride (520.8 mg, 2.39 mmol) was added, and 2 M NaOH was added to the mixture until pH 
10 was reached. The reaction mixture was stirred at room temperature. After 23 hours, the 
solution was concentrated in vacuo, and 15% citric acid aqueous solution was added until pH 4 
was reached. The white precipitate was filtered off and dried under vacuum to provide 2-((tert-
butoxycarbonyl)amino)benzoic acid (SI-1, 496.7 mg, 96%) as a white solid. 1H NMR, 600 MHz, 
chloroform-d: δ (ppm) 10.06 (s, 1H), 8.47 (dd, J = 8.7, 0.9 Hz, 1H), 8.08 (dd, J = 7.9, 1.5 Hz, 
1H), 7.57 (dt, J = 7.9, 1.5 Hz, 1H), 7.03 (dt, J = 7.2, 1.2 Hz, 1H), 1.55 (s, 9H). 
 
Synthesis of N-β-(6-(2ʹ-aminobenzoyl)-glucopyranosyl) indole (iglu#3, 34) 
 
 
To a stirred solution of N-(tert-butoxycarbonyl)anthranilic acid70 (SI-1, 10 mg, 0.042 mmol) in 
dimethylformamide, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl, 
20.1 mg, 0.105 mmol) was added. The mixture was stirred at room temperature for 5 min, and 
4-dimethylaminopyridine (DMAP, 18.1 mg, 0.105 mmol) and N-β-glucopyranosyl indole (iglu#1, 
15, 9.8 mg, 0.0351 mmol) were added. The reaction mixture was stirred at room temperature. 
After 5 hours, the mixture was concentrated in vacuo to yield a viscous oil, which was dissolved 
in 1.4 mL of a 5:2 mixture of dichloromethane and methanol. Trifluoroacetic acid (TFA, 0.5 mL) 
was added slowly and the reaction mixture was stirred at room temperature. After 3 hours, the 
mixture was concentrated in vacuo. Preparative HPLC provided a pure sample of iglu#3 (34, 0.8 
mg, 5.7%). See Table 5 for NMR spectroscopic data of iglu#3.  
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HRMS (ESI) m/z: [M - H]- calcd for C21H21N2O6
- 397.13938; found 397.14017. 
 
Synthesis of N-β-(6-nicotinoylglucopyranosyl) indole (iglu#5, SI-2) 
 
 
To a stirred solution of nicotinic acid (7.3 mg, 0.059 mmol) in a mixture of dimethylformamide 
and dichloromethane (1:1), EDC·HCl (28.4 mg, 0.148 mmol) was added. The mixture was 
stirred at room temperature for 30 min, before DMAP (18.1 mg, 0.148 mmol) and N-β-
glucopyranosyl indole (iglu#1, 15, 13.8 mg, 0.0494 mmol) were added. The reaction mixture 
was stirred at room temperature for 20 h, the mixture was concentrated in vacuo, and flash 
column chromatography on silica using a gradient of 0-25% methanol in dichloromethane 
afforded iglu#5 (SI-2, 2.5 mg, 13.9%) as a colorless oil. See Table 6 for NMR spectroscopic 
data of iglu#5. 
HRMS (ESI) m/z: [M + H]+ calcd for C20H21N2O6
+ 385.13941; found 385.14038. 
 
Synthesis of N-β-(6-(2ʹ-methylbut-2ʹE-enoyl)-glucopyranosyl) indole (iglu#7, SI-3) 
 
To a stirred solution of tiglic acid (5.0 mg, 0.050 mmol) in a 1:1 mixture of dimethylformamide 
and dichloromethane, EDC·HCl (23.9 mg, 0.125 mmol) was added. The mixture was stirred at 
room temperature for 30 min, and DMAP (15.2 mg, 0.125 mmol) and N-β-glucopyranosyl indole 
(iglu#1, 15, 11.6 mg, 0.0416 mmol) were added. The reaction mixture was stirred at room 
temperature for 22 hours and then concentrated in vacuo. Flash column chromatography on 
silica using a gradient of 0-30% methanol in dichloromethane afforded iglu#7 (SI-3, 2.5 mg, 
11.3%) as a colorless oil. See Table 7 for NMR spectroscopic data of iglu#7. 
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HRMS (ESI) m/z: [M + H]+ calcd for C19H24NO6
+ 362.15981; found 362.16025. 
 
Synthesis of N-β-(6-(pyrrole-2ʹ-carbonyl)-glucopyranosyl) indole (iglu#9, SI-4) 
 
To a suspension of pyrrole-2-carboxylic acid (6.0 mg, 0.054 mmol) in dichloromethane, oxalyl 
chloride (14 µL, 0.163 mmol) was added slowly, followed by dimethylformamide (1 µL, 0.0129 
mmol). The mixture was stirred at room temperature for 18 hours and then concentrated to 
dryness in vacuo. The residue was re-dissolved in dimethylformamide (2 mL) containing N-β-
glucopyranosyl indole (iglu#1, 15, 10.8 mg, 0.0387 mmol). Triethylamine (45 µL, 0.324 mmol) 
was added, and the reaction was stirred at 35 °C for 7 days. Subsequently the mixture was 
concentrated in vacuo, and flash column chromatography on silica using a gradient of 0-30% 
methanol in dimethylformamide afforded iglu#9 (SI-4, 1.5 mg, 10.4%) as a colorless oil. See 
Table 8 for NMR spectroscopic data of iglu#9. 
HRMS (ESI) m/z: [M + H]+ calcd for C19H21N2O6
+ 373.13941; found 373.14026. 
 
Synthesis of an HPLC standard of ((2R,3S,4S,5R,6S)-6-((2-aminobenzoyl)oxy)-3,4,5-
trihydroxytetrahydro-2H-pyran-2-yl)methyl 2-aminobenzoate (angl#3, SI-5) 
 
 
To a stirred solution of Boc-AA (2 mg, 0.00 84mmol) in dimethylformamide, 1-(3- 
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl) (3.9 mg, 0.0203 mmol) was 
added. The mixture was stirred at room temperature for 5 min, and 4-dimethylaminopyridine 
(DMAP) (2.5 mg, 0.0203 mmol) and angl#1 (17, 2 mg, 0.0068 mmol) were added. The reaction 
mixture was stirred at room temperature. After 5 hours, the mixture was concentrated in vacuo. 
The crude product was dissolved in 0.55 mL dichloromethane and methanol (10:1) and 
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trifluoroacetic acid (TFA, 500 µL) was added slowly. The reaction mixture was stirred at room 
temperature for 3 hours then was concentrated in vacuo, affording angl#3 (SI-5). 
HRMS (ESI) m/z: [M + H]+ calcd for C20H23N2O7
+ 403.14998; found 403.15100. 
 
Synthesis of an HPLC standard of N-(p-aminobenzoyl)glutamate (PABA-glutamate) (29)  
 
p-Aminobenzoic acid (Chem-Impex) (8) was dissolved in warm dichloromethane (DCM) 
containing triethylamine (0.1 eq). EDC·HCl (Amresco Biochemicals) (1 eq) and di-tert-butyl 
glutamate (1 eq) was added to the reaction mixture. N,N-Dimethylaminopyridine (1.1 eq) was 
then added to the mixture and the resulting mixture was stirred at room temperature for 24 hr 
and then extracted with ethyl acetate. The organic layer was dried with sodium sulfate and 
evaporated to dryness in vacuo. The crude product was dissolved in DCM, and trifluoroacetic 
acid (TFA) was added (100 eq). The reaction was then stirred for 6 hr at room temperature. TFA 
and DCM were evaporated off to yield crude PABA-glutamate (29). 1H NMR, 600 MHz, 
methanol: δ (ppm) 7.93 (d, 8.6 Hz, 2H), 7.37 (d, 8.5 Hz, 2H), 4.61 (dd, 5.0, 9.3 Hz, 1H), 2.09-
2.28 (m, 4H).  
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Tables 
 
Table 1. MS2 data of glo-1 dependent features presented in this manuscript.  
Attached as a separate file.  
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Table 2. BLASTp results from the WormBase BLAST engine when searching against 
the amino acid sequence of UAR-1 and CRISPR/Cas9 targets for this study (red). . 
Sequence Score E-value 
C01B10.10  280    2e-75 
C01B10.4a  260    2e-69 
T22D1.11  248    7e-66 
C42D4.2  233    4e-61 
C17H12.4  231    1e-60 
C23H4.4a  225  8e-59 
C23H4.7  199    6e-51 
C23H4.3  194    1e-49 
E01G6.3  193    3e-49 
C23H4.2  168    1e-41 
T02B5.1  157    2e-38 
F15A8.6a  154    1e-37 
F15A8.6b  154    1e-37 
ZC376.3  153    3e-37 
T02B5.3  150    2e-36 
ZC376.2b  148    1e-35 
ZC376.2a  147    2e-35 
F56C11.6b  141    1e-33 
F56C11.6a  137    2e-32 
Y71H2AM.13 136    5e-32 
ZC376.1  135    1e-31 
R173.3 r 129    6e-30 
T07H6.1a  127    2e-29 
T28C12.4a  124    1e-28 
T28C12.4b  124    2e-28 
K07C11.4  119    6e-27 
R12A1.4  118    1e-26 
K11G9.2  116    4e-26 
02B12.4  115    8e-26 
Y75B8A.3  114    3e-25 
Y48B6A.8  113    4e-25 
F13H6.3  111    2e-24 
Y48B6A.7  109    5e-24 
09B12.1  108    9e-24 
K11G9.1  108    2e-23 
ZC376.2c  105    7e-23 
F07C4.12b  105    7e-23 
C52A10.1  101    1e-21 
Y44E3A.2  101    2e-21 
K11G9.3   99    1e-20 
C52A10.2   97    3e-20 
C40C9.5d   96    6e-20 
C40C9.5b   96    6e-20 
C40C9.5a   96    6e-20 
F55D10.3   96    1e-19 
C40C9.5f   94    2e-19 
C01B10.4b   94    2e-19 
C40C9.5g   94    2e-19 
C40C9.5c   94    3e-19 
C40C9.5e   94    3e-19 
B0238.7   93    4e-19 
B0238.1   92    1e-18 
F55F3.2b   83    6e-16 
F55F3.2a   83    7e-16 
C23H4.4b   50    5e-06 
Y43F8A.3a   42    0.002 
Y43F8A.3b   35    0.18  
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Table 3. List of C. elegans strains used in this study. 
 
Strain Name Identifier Description Associated Metabolites  
PS8031 cest-1.1 (sy1180) cest-1.1 null uglas#1 uglas#11 
PS8032 cest-1.1 (sy1181) cest-1.1 null uglas#1 uglas#11 
PS8259 cest-1.1 (sy1180 sy1250) 
cest-1.1 null reverted to WT 
sequence 
uglas#1 uglas#11 
PS8260 cest-1.1 (sy1180 sy1251) 
cest-1.1 null reverted to WT 
sequence 
uglas#1 uglas#11 
PS8261 cest-1.1 (sy1181 sy1252) 
cest-1.1 null reverted to WT 
sequence 
 uglas#1 uglas#11 
PS8262 cest-1.1 (sy1181 sy1253) 
cest-1.1 null reverted to WT 
sequence 
 uglas#1 uglas#11 
PS8008 cest-2.2 (sy1170) cest-2.2 null ascr#8, ascr#81, ascr#82 
PS8009 cest-2.2(sy1171) cest-2.2 null ascr#8, ascr#81, ascr#82 
PS8236 cest-2.2(sy1170 sy1236) 
cest-2.2 null reverted to WT 
sequence 
ascr#8, ascr#81, ascr#82 
PS8238 cest-2.2(sy1171 sy1238) 
cest-2.2 null reverted to WT 
sequence 
ascr#8, ascr#81, ascr#82 
PS8116 cest-4 (sy1192) cest-4 null  iglu class modular glucosides 
PS8117 cest-4(sy1193) cest-4 null iglu class modular glucosides 
JJ1271 glo-1 (zu437) glo-1 null 
Most known modular 
ascarosides/glucosides 
PS8781 cest-4 (sy1192) 
cest-4 null reverted to WT 
sequence 
iglu class modular glucosides 
PS8782 cest-4 (sy1193) 
cest-4 null reverted to WT 
sequence 
iglu class modular glucosides 
PS8783 cest-4 (sy1194) 
cest-4 null reverted to WT 
sequence 
iglu class modular glucosides 
PS8784 cest-4 (sy1195) 
cest-4 null reverted to WT 
sequence 
iglu class modular glucosides 
PS8515 CBR-glo-1-A (sy1382) C. briggsae glo-1 null 
Most known modular 
ascarosides/glucosides 
PS8516 CBR-glo-1-B (sy1383) C. briggsae glo-1 null 
Most known modular 
ascarosides/glucosides 
PS8029 cest-19(sy1178) cest-19 null Undetermined 
PS8030 cest-19(sy1179) cest-19 null Undetermined 
PS8033 cest-33(sy1182) cest-33 null Undetermined 
PS8034 cest-33(sy1183) cest-33 null Undetermined 
RB2053 ges-1 (ok2716) ges-1 null Undetermined 
RB1804 cest-6(ok2338) cest-6 null Undetermined 
DP683 cest-1.1(dp683)  cest-1.1 (S213A) point mutant uglas#1 uglas#11 
FCS02 cest-2.2-mCherry cest-2.2 C-terminal mCherry ascr#8, ascr#81, ascr#82 
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Table 4. DNA oligonucleotides used for this study. 
 
Target 
Gene 
Sequence 
Name 
Strain Allelle Guide 
Sequence 
ssDNA Repair Oligonucleotide Sequence 
cest-1.1 T02B5.1 PS8031, 
PS8032 
sy1180, 
sy1181 
ACTCCTTCCCA
TGATTTCGG 
TATTCATTTGTTACCAAAACTCCTTCCCATGATTT
GCTAGCTTATCACTTAGTCACCTCTGCTCTGGAC
AAACTTCCCCGGTGGACGGGGTTTTCGATATCGA
AGGTCTCCAATTG 
cest-2.2 ZC376.2 PS8008, 
PS8009 
sy1170, 
sy1171 
GGAGGCGAAG
GAGTATAAAG 
CCCTGGGACGGAGTTTTGGAGGCGAAGGAGTAT
AGGGAAGTTTGTCCAGAGCAGAGGTGACTAAGT
GATAAGCTAGCAAGCGGCTTGTATGAGTGATCAG
AAGTAAGAGATA 
cest-4 C17H12.4 PS8116, 
PS8117 
sy1192, 
sy1193 
ACTCCGGTCCA
TTTCTCAGG 
CATACCTTTTGCATTTCTCACTCCGGTCCATTTCT
CGCTAGCTTATCACTTAGTCACCTCTGCTCTGGA
CAAACTTCCCAGGCGGTTCTGGTTTTTGAAATCTT
AATTTTCCAATTG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprintthis version posted October 12, 2020. . https://doi.org/10.1101/2020.08.22.262956doi: bioRxiv preprint 
34 
 
Table 5. NMR spectroscopic data for iglu#3 (34). 1H (600 MHz), HSQC, and HMBC NMR 
spectroscopic data were acquired in methanol-d4. Chemical shifts were referenced to 
δ(CHD2OD) = 3.31 ppm and δ(
13CHD2OD) = 49.00 ppm. 
 
Position δ 13C ppm] δ 1H [ppm] JHH[Hz]) HMBC 
1 86.9 5.51 (J1,2 = 9.3) C-2, C-3, C-5, C-2’, C-9’ 
2 73.0 3.99 (J2,3 = 9.0) C-1, C-3 
3 78.7 3.65 (J3,4 = 9.0) C-4 
4 71.3 3.64 (J4,5 = 9.1) C-3 
5 77.5 3.91 (J5,6a = 5.5) C-4 
6a 64.1 4.43 (J6a,6b = 12.1) C-5, C-1′′ 
6b  4.67 (J5,6b = 2.2) C-4, C-1′′ 
2′ 126.3 7.37 (J2’,3’ = 3.3) C-1 (weak), C-3', C-4’, C-8’ (weak), C-9’ 
3′ 102.9 6.48  
4′ 130.4   
5′ 121.4 7.52 (J5’,6’ = 8.0) C-3’, C-7’, C-9’ 
6′ 120.8 
7.03 (J6’,7’ = 7.4, 
J3’,6’ = 1.1) 
C-4’, C-8’ 
7′ 122.4 7.06 C-5’, C-9’ 
8′ 111.5 7.53 C-4’, C-6’ 
9′ 137.5   
1′′ 168.6   
2′′ 112.8   
3′′ 132.1 
7.90 (J3’’,4’’ = 8.2, 
J3’’,5’’ = 1.4) 
C-1’’, C-5’’, C-7’’ 
4′′ 118.2 6.73 (J4’’,5’’ = 7.6) C-2’’, C-6’’ 
5′′ 135.0 7.32 (J5’’,6’’ = 7.8) C-3’’, C-7’’ 
6′′ 118.6 6.84 C-2’’, C-4’’ 
7′′ 149.9   
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Table 6. NMR spectroscopic data for iglu#5 (SI-2). 1H (600 MHz), HSQC, and HMBC NMR 
spectroscopic data were acquired in methanol-d4. Chemical shifts were referenced to 
δ(CHD2OD) = 3.31 ppm and δ(
13CHD2OD) = 49.00 ppm. 
 
Position δ 13C ppm] δ 1H [ppm] JHH[Hz]) HMBC 
1 86.9 5.51 (J1,2 = 9.2) C-2, C-3, C-5, C-2’, C-9’ 
2 73.0 4.00 (J2,3 = 9.0) C-1, C-3 
3 78.7 3.65 (J3,4 = 9.0) C-4 
4 71.4 3.63 (J4,5 = 8.9) C-3 
5 77.4 3.95 (J5,6a = 5.8) C-4 
6a 65.3 4.51 (J6a,6b = 12.1) C-4, C-5, C-1′′ 
6b  4.75 (J5,6b = 2.3) C-4, C-5, C-1′′ 
2′ 126.4 7.37 (J2’,3’ = 3.5) C-3', C-4’, C-9’ 
3′ 103.1 6.47 C-2', C-4’, C-9’ 
4′ 130.5   
5′ 121.4 7.51 (J5’,6’ = 7.9) C-4’, C-6’, C-9’ 
6′ 120.8 
7.01 (J6’,7’ = 7.5, 
J3’,6’ = 1.2) 
C-4’, C-8’ 
7′ 122.5 7.05 C-4’, C-5’, C-8’, C-9’ 
8′ 111.4 7.49 C-4’, C-6’ 
9′ 137.6   
1′′ 165.8   
2′′ 127.7   
3′′ 150.8 
9.12 (J3’’,6’’ = 0.5, 
J3’’,7’’ = 2.0) 
C-2’’, C-5’’, C-7’’ 
5′′ 153.7 
8.74 (J5’’,6’’ = 4.9, 
J5’’’,7’’ = 1.7) 
C-3’’, C-6’’, C-7’’ 
6′′ 125.1 7.54 (J6’’’,7’’ = 8.0) C-2’’, C-5’’ 
7′′ 138.9 8.37 C-1’’, C-2’’, C-5’’ 
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Table 7. NMR spectroscopic data for iglu#7 (SI-3). 1H (600 MHz), HSQC, and HMBC NMR 
spectroscopic data were acquired in methanol-d4. Chemical shifts were referenced to 
δ(CHD2OD) = 3.31 ppm and δ(
13CHD2OD) = 49.00 ppm. 
 
Position δ 13C ppm] δ 1H [ppm] JHH[Hz]) HMBC 
1 86.9 5.46 (J1,2 = 9.1) C-2, C-3, C-5, C-2’, C-9’ 
2 73.2 3.96 (J2,3 = 9.0) C-1, C-3 
3 78.9 3.61 (J3,4 = 9.0) C-2, C-4 
4 71.4 3.55 (J4,5 = 9.6) C-3, C-5, C-6 
5 77.6 3.81 (J5,6a = 5.6) C-1 (weak), C-3, C-4 
6a 64.5 4.27 (J6a,6b = 11.9) C-4, C-5, C-1′′ 
6b  4.49 (J5,6b = 2.2) C-4, C-5, C-1′′ 
2′ 126.6 7.35 (J2’,3’ = 3.5) 
C-1 (weak), C-3', C-4’, C-5’ (weak), C-8’ 
(weak), C-9’ 
3′ 103.2 6.48  
4′ 130.6   
5′ 121.6 7.53 (J5’,6’ = 7.9) C-3’, C-7’, C-9’ 
6′ 120.9 
7.05 (J6’,7’ = 7.5,  
J3’,6’ = 1.1) 
C-4’, C-8’, C-9’ (weak) 
7′ 122.5 7.11 C-5’, C-8’ (weak), C-9’ 
8′ 111.7 7.50 C-4’, C-6’ 
9′ 137.6   
1′′ 169.2   
2′′ 129.3   
3′′ 138.9 6.87 (J3’’,4’’ = 6.8) C-1’’, C-4’’, C-5’’ 
4′′ 14.2 1.79 C-2’’, C-3’’ 
5′′ 11.9 1.81 C-1’’, C-2’’, C-3’’ 
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Table 8. NMR spectroscopic data for iglu#9 (SI-4). 1H (600 MHz), HSQC, and HMBC NMR 
spectroscopic data were acquired in methanol-d4. Chemical shifts were referenced to 
δ(CHD2OD) = 3.31 ppm and δ(
13CHD2OD) = 49.00 ppm. 
 
Position δ 13C ppm] δ 1H [ppm] JHH[Hz]) HMBC 
1 86.9 5.47 (J1,2 = 9.1) C-2, C-3, C-5, C-2’, C-9’ 
2 73.2 3.96 (J2,3 = 9.0) C-1, C-3 
3 78.7 3.62 (J3,4 = 9.8) C-4 
4 71.3 3.61 (J4,5 = 9.7) C-3 
5 77.9 3.86 (J5,6a = 5.7)  
6a 63.9 4.38 (J6a,6b = 11.9) C-5, C-1′′ 
6b  4.68 (J5,6b = 2.1) C-4, C-1′′ 
2′ 126.6 7.36 (J2’,3’ = 3.4) C-3', C-4’, C-9’ 
3′ 103.1 6.47 C-2', C-4’, C-9’ 
4′ 130.6   
5′ 121.4 7.52 (J5’,6’ = 7.8) C-7’, C-9’ 
6′ 120.8 
7.02 (J6’,7’ = 7.3,  
J3’,6’ = 1.2) 
C-4’, C-8’ 
7′ 122.4 7.05 C-5’, C-9’ 
8′ 111.6 7.50 C-4’, C-6’ 
9′ 137.4   
1′′ 162.4   
2′′ 123.0   
4′′ 124.7 
6.96 (J4’’,5’’ = 2.5,  
J4’’,6’’ = 1.4) 
C-2’’, C-5’’, C-6’’ 
5′′ 110.6 6.20 (J5’’,6’’ = 3.8) C-2’’(weak), C-4’’(weak) 
6′′ 116.8 6.90 C-2’’, C-4’’, C-5’’ 
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Table 9. List of all modular metabolites referred to in the text and Figures. 
Compound 
number 
SMID ID IUPAC Name Evidence Structure 
1 icas#3 (R)-8-(((2R,3R,5R,6S)-5-((1H-indole-
3-carbonyl)oxy)-3-hydroxy-6-
methyltetrahydro-2H-pyran-2-
yl)oxy)nonanoic acid 
Previously identified via 
synthesis (Srinivasan et al. 
2012)
16
 
 
2 ascr#8 4-((R,E)-6-(((2R,3R,5R,6S)-3,5-
dihydroxy-6-methyltetrahydro-2H-
pyran-2-yl)oxy)hept-2-
enamido)benzoic acid 
Previously identified via 
synthesis (Pungaliya et al. 
2008)
13
 
 
3 uglas#11 (2R,3R,4S,5R,6R)-5-hydroxy-6-
(hydroxymethyl)-4-(phosphonooxy)-
2-(2,6,8-trioxo-1,2,6,7,8,9-
hexahydro-3H-purin-3-yl)tetrahydro-
2H-pyran-3-yl (R)-6-
(((2R,3R,5R,6S)-3,5-dihydroxy-6-
methyltetrahydro-2H-pyran-2-
yl)oxy)heptanoate 
Previously identified via 
synthesis (Curtis et al. 
2020)
12
 
 
4 ubas#3 (R)-4-(((2R,3R,5R,6S)-3-hydroxy-6-
methyl-5-(((R)-2-methyl-3-
ureidopropanoyl)oxy)tetrahydro-2H-
pyran-2-yl)oxy)pentanoic acid 
Previously inferred via 
tandem mass spectrometry 
(Falcke et al. 2018)
26
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5 ascr#1 (R)-6-(((2R,3R,5R,6S)-3,5-
dihydroxy-6-methyltetrahydro-2H-
pyran-2-yl)oxy)heptanoic acid 
Previously identified via NMR 
and synthesis (Jeong et al. 
2005)
7
 
 
6 gluric#1 3-((2R,3R,4S,5S,6R)-3,4,5-
trihydroxy-6-
(hydroxymethyl)tetrahydro-2H-pyran-
2-yl)-7,9-dihydro-1H-purine-
2,6,8(3H)-trione 
Previously identified via 
synthesis (Curtis et al. 
2020)
12
 
 
7 ascr#7 (R,E)-6-(((2R,3R,5R,6S)-3,5-
dihydroxy-6-methyltetrahydro-2H-
pyran-2-yl)oxy)hept-2-enoic acid 
Previously identified via 
synthesis (Pungaliya et al. 
2008)
13
 
 
8 PABA 4-aminobenzoic acid Commercial product (Sigma-
Aldrich) 
 
9 ascr#3 (R,E)-8-(((2R,3R,5R,6S)-3,5-
dihydroxy-6-methyltetrahydro-2H-
pyran-2-yl)oxy)non-2-enoic acid 
Previously identified via 
synthesis (Butcher et al. 
2007)
6
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10 ascr#10 (R)-8-(((2R,3R,5R,6S)-3,5-
dihydroxy-6-methyltetrahydro-2H-
pyran-2-yl)oxy)nonanoic acid 
Previously identified via 
synthesis (Srinivasan et al. 
2012)
16
 
 
11  1H-indole-3-carboxylic acid Commercial product (Sigma-
Aldrich) 
 
12  (R)-4-((2-hydroxy-2-(4-
hydroxyphenyl)ethyl)amino)-4-
oxobutanoic acid 
Identified via synthesis (This 
manuscript) 
 
13 iglas#1 ((2R,3S,4S,5R,6R)-3,4,5-trihydroxy-
6-(1H-indol-1-yl)tetrahydro-2H-
pyran-2-yl)methyl (R)-6-
(((2R,3R,5R,6S)-3,5-dihydroxy-6-
methyltetrahydro-2H-pyran-2-
yl)oxy)heptanoate 
Previously identified via 
synthesis (Artyukhin et al. 
2018)
2
 
 
14 glas#10 (2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-
(hydroxymethyl)tetrahydro-2H-pyran-
2-yl (R)-8-(((2R,3R,5R,6S)-3,5-
dihydroxy-6-methyltetrahydro-2H-
pyran-2-yl)oxy)nonanoate 
Previously identified via NMR 
and synthesis (Coburn et al. 
2013)
69
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15 iglu#1 (2R,3S,4S,5R,6R)-2-
(hydroxymethyl)-6-(1H-indol-1-
yl)tetrahydro-2H-pyran-3,4,5-triol 
Previously identified via NMR 
and synthesis (Coburn et al. 
2013)
69
 
 
16 iglu#2 (2R,3R,4S,5R,6R)-3,5-dihydroxy-2-
(hydroxymethyl)-6-(1H-indol-1-
yl)tetrahydro-2H-pyran-4-yl 
dihydrogen phosphate 
Previously identified via NMR 
(Coburn et al. 2013)
69
 
 
17 angl#1 (2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-
(hydroxymethyl)tetrahydro-2H-pyran-
2-yl 2-aminobenzoate 
Previously identified via NMR 
and synthesis (Coburn et al. 
2013)
69
 
 
18 angl#2 (2S,3R,4S,5R,6R)-3,5-dihydroxy-6-
(hydroxymethyl)-4-
(phosphonooxy)tetrahydro-2H-pyran-
2-yl 2-aminobenzoate 
Previously identified via NMR 
(Coburn et al. 2013)
69
 
 
19 iglu#4 ((2R,3R,4S,5R,6R)-3,5-dihydroxy-6-
(1H-indol-1-yl)-4-
(phosphonooxy)tetrahydro-2H-pyran-
2-yl)methyl 2-aminobenzoate 
Proposed structure, based on 
identification of non-
phosphorylated derivative 
(34) via synthesis (This 
manuscript) 
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20 iglu#6 ((2R,3R,4S,5R,6R)-3,5-dihydroxy-6-
(1H-indol-1-yl)-4-
(phosphonooxy)tetrahydro-2H-pyran-
2-yl)methyl nicotinate 
Proposed structure, based on 
identification of non-
phosphorylated derivative (SI-
2) via synthesis (This 
manuscript) 
 
21 iglu#8 ((2R,3R,4S,5R,6R)-3,5-dihydroxy-6-
(1H-indol-1-yl)-4-
(phosphonooxy)tetrahydro-2H-pyran-
2-yl)methyl (E)-2-methylbut-2-enoate 
Proposed structure, based on 
identification of non-
phosphorylated derivative (SI-
3) via synthesis (This 
manuscript) 
 
22 iglu#10 ((2R,3R,4S,5R,6R)-3,5-dihydroxy-6-
(1H-indol-1-yl)-4-
(phosphonooxy)tetrahydro-2H-pyran-
2-yl)methyl 1H-pyrrole-2-carboxylate 
Proposed structure, based on 
identification of non-
phosphorylated derivative (SI-
4) via synthesis (This 
manuscript) 
 
23 iglu#12 ((2R,3R,4S,5R,6R)-3,5-dihydroxy-6-
(1H-indol-1-yl)-4-
(phosphonooxy)tetrahydro-2H-pyran-
2-yl)methyl benzoate 
Proposed structure. Inferred 
via tandem mass 
spectrometry (This 
manuscript) 
 
24 iglu#41 (2R,3R,4S,5R,6R)-6-(((2-
aminobenzoyl)oxy)methyl)-5-
hydroxy-2-(1H-indol-1-yl)-4-
(phosphonooxy)tetrahydro-2H-pyran-
3-yl 1H-pyrrole-2-carboxylate 
Proposed structure. Inferred 
from iglu#3 (34) via tandem 
mass spectrometry (This 
manuscript) 
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25 angl#4 ((2R,3R,4S,5R,6S)-6-((2-
aminobenzoyl)oxy)-3,5-dihydroxy-4-
(phosphonooxy)tetrahydro-2H-pyran-
2-yl)methyl 2-aminobenzoate 
Proposed structure. Inferred 
from angl#3 (SI 5) via tandem 
mass spectrometry (This 
manuscript) O
HO
H2O3PO
OH
O
O
O
H2N
ONH2
 
26 tyglu#4 ((2R,3R,4S,5R,6R)-5-((2-
aminobenzoyl)oxy)-3-hydroxy-6-((4-
(2-aminoethyl)phenoxy)-4-
(phosphonooxy)tetrahydro-2H-pyran-
2-yl)methyl 2-aminobenzoate 
Proposed structure. Initially 
described (O’Donnell et al. 
2020)
35
 and further inferred 
via tandem mass 
spectrometry (This 
manuscript) 
 
 
O
HO
H2O3PO
O
O
O
ONH2
O NH2
H2N
  
27 ascr#81 (4-((R,E)-6-(((2R,3R,5R,6S)-3,5-
dihydroxy-6-methyltetrahydro-2H-
pyran-2-yl)oxy)hept-2-
enamido)benzoyl)-L-glutamic acid 
Identified via synthesis 
(Artyukhin et al. 2018)
2
 
 
28 ascr#82 ((S)-4-carboxy-4-(4-((R,E)-6-
(((2R,3R,5R,6S)-3,5-dihydroxy-6-
methyltetrahydro-2H-pyran-2-
yl)oxy)hept-2-
enamido)benzamido)butanoyl)-L-
glutamic acid 
Previously inferred via 
tandem mass spectrometry 
(Artyukhin et al. 2018)
2
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29 PABA-glu (4-aminobenzoyl)-L-glutamic acid Identified via synthesis (This 
manuscript) 
 
30 uglas#1 (2R,3R,4S,5S,6R)-4,5-dihydroxy-6-
(hydroxymethyl)-2-(2,6,8-trioxo-
1,2,6,7,8,9-hexahydro-3H-purin-3-
yl)tetrahydro-2H-pyran-3-yl (R)-6-
(((2R,3R,5R,6S)-3,5-dihydroxy-6-
methyltetrahydro-2H-pyran-2-
yl)oxy)heptanoate 
Identified via synthesis (Curtis 
et al. 2020)
12
 
 
31 uglas#14 ((2R,3S,4S,5R,6R)-3,4,5-trihydroxy-
6-(2,6,8-trioxo-1,2,6,7,8,9-
hexahydro-3H-purin-3-yl)tetrahydro-
2H-pyran-2-yl)methyl (R)-6-
(((2R,3R,5R,6S)-3,5-dihydroxy-6-
methyltetrahydro-2H-pyran-2-
yl)oxy)heptanoate 
Identified via synthesis (Curtis 
et al. 2020)
12
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32 uglas#15 ((2R,3R,4S,5R,6R)-3,5-dihydroxy-4-
(phosphonooxy)-6-(2,6,8-trioxo-
1,2,6,7,8,9-hexahydro-3H-purin-3-
yl)tetrahydro-2H-pyran-2-yl)methyl 
(R)-6-(((2R,3R,5R,6S)-3,5-
dihydroxy-6-methyltetrahydro-2H-
pyran-2-yl)oxy)heptanoate 
Previously inferred via 
tandem mass spectrometry 
(Artyukhin et al. 2018 and 
Curtis et al. 2020)
2,12
 
 
33  2-aminobenzoic acid Commercial product (Sigma-
Aldrich) 
 
34 iglu#3 ((2R,3S,4S,5R,6R)-3,4,5-trihydroxy-
6-(1H-indol-1-yl)tetrahydro-2H-
pyran-2-yl)methyl 2-aminobenzoate 
Identified via synthesis (This 
manuscript) 
 
35 icas#2 (2S,3R,5R,6R)-5-hydroxy-2-methyl-
6-(((R)-5-oxohexan-2-
yl)oxy)tetrahydro-2H-pyran-3-yl 1H-
indole-3-carboxylate 
Identified via synthesis (Dong 
et al. 2016)
23
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36 icas#6.2 (2S,3R,5R,6R)-5-hydroxy-6-
(((2R,5S)-5-hydroxyhexan-2-yl)oxy)-
2-methyltetrahydro-2H-pyran-3-yl 
1H-indole-3-carboxylate 
Identified via synthesis (Dong 
et al. 2016)
23
 
 
SI 1  2-((tert-butoxycarbonyl)-
amino)benzoic acid 
Characterized via synthesis 
(This manuscript) 
 
SI 2 iglu#5 ((2R,3S,4S,5R,6R)-3,4,5-trihydroxy-
6-(1H-indol-1-yl)tetrahydro-2H-
pyran-2-yl)methyl nicotinate 
Identified via synthesis (This 
manuscript) 
 
SI 3 iglu#7 ((2R,3S,4S,5R,6R)-3,4,5-trihydroxy-
6-(1H-indol-1-yl)tetrahydro-2H-
pyran-2-yl)methyl (E)-2-methylbut-2-
enoate 
Identified via synthesis (This 
manuscript) 
 
SI 4 iglu#9 ((2R,3S,4S,5R,6R)-3,4,5-trihydroxy-
6-(1H-indol-1-yl)tetrahydro-2H-
pyran-2-yl)methyl 1H-pyrrole-2-
carboxylate 
Identified via synthesis (This 
manuscript) 
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SI 5 angl#3 ((2R,3S,4S,5R,6S)-6-((2-
aminobenzoyl)oxy)-3,4,5-
trihydroxytetrahydro-2H-pyran-2-
yl)methyl 2-aminobenzoate 
Proposed structure based on 
synthesis of a reference 
sample for MS (This 
manuscript) 
 
SI 6 tyglu#6 (2R,3R,4S,5S,6R)-6-(((2-
aminobenzoyl)oxy)methyl)-2-((4-(2-
aminoethyl)-phenoxy)-5-hydroxy-4-
(phosphonooxy)-tetrahydro-2H-
pyran-3-yl nicotinate  
Proposed structure. Initially 
described (O’Donnell et al. 
2020)
35
 and further inferred 
via tandem mass 
spectrometry (This 
manuscript) 
 
O
HO
H2O3PO
O
O
O
ONH2
O
N
H2N
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Table 10. Compiled data depicted in Figures 1, 3, 4, S6, S7, S9, S10, S11, S13, and 
S16.  
 
Attached as a separate file.  
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